BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 33275265)

  • 41. [The Risk and Survival Analysis of Multiple Malignancies in Hematologic Malignancy Patients: A Single Chinese Center Retrospective Study, 2009 through 2017].
    Zhang XC; Fan L; Lu H; Qian SX; Chen LJ; Xu W; Li JY; Qu XY; Zhao XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):389-395. PubMed ID: 37096510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical characteristics and outcomes of COVID-19 infection in Chinese patients with hematologic malignancies in the Omicron era.
    Li X; Zhao A; Jiang H; Lu Y; Le J; Xie Y; Hu M; Zeng H; Zhao J; Zhou M; Zhou H; Chen L; Zhu W; Ouyang G; Qiu H; Jiang S; Guo Q; Qian W; Liang Y
    Hematology; 2023 Dec; 28(1):2288477. PubMed ID: 38038062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue.
    Arcani R; Colle J; Cauchois R; Koubi M; Jarrot PA; Jean R; Boyer A; Lachamp J; Tichadou A; Couderc AL; Farnault L; Costello R; Venton G; Kaplanski G
    Ann Hematol; 2021 Nov; 100(11):2799-2803. PubMed ID: 34518918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic Lymphocytic Leukemia Concomitant with COVID 19: A Case Report.
    Ali E; Badawi M; Abdelmahmuod E; Kohla S; Yassin MA
    Am J Case Rep; 2020 Oct; 21():e926062. PubMed ID: 33098641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical presentations and outcomes of children with cancer and COVID-19: A systematic review.
    Meena JP; Kumar Gupta A; Tanwar P; Ram Jat K; Mohan Pandey R; Seth R
    Pediatr Blood Cancer; 2021 Jun; 68(6):e29005. PubMed ID: 33719167
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic.
    Čerňan M; Szotkowski T; Obr A; Látal V; Hluší A; Krhovská P; Klementová O; Kolář M; Sauer P; Faber E; Fürst T; Papajík T
    Clin Lymphoma Myeloma Leuk; 2021 Sep; 21(9):606-612. PubMed ID: 34083176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes and Clinical Characteristics of Intracranial Hemorrhage in Patients with Hematologic Malignancies: A Systematic Literature Review.
    Raghavan A; Wright CH; Wright JM; Jensen K; Malloy P; Elder T; Burant C; Sajatovic M; Hoffer A
    World Neurosurg; 2020 Dec; 144():e15-e24. PubMed ID: 32565374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spectrum of hematological malignancies and peripheral cytopenias.
    Jha A
    J Nepal Health Res Counc; 2013 Sep; 11(25):273-8. PubMed ID: 24908530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pemphigus and hematologic malignancies: A population-based study of 11,859 patients.
    Kridin K; Zelber-Sagi S; Comaneshter D; Batat E; Cohen AD
    J Am Acad Dermatol; 2018 Jun; 78(6):1084-1089.e1. PubMed ID: 29198780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impaired erythropoietin response to anemia in patients with lymphocytic malignancies.
    Han B; Shi YK; Zhu J; He XH; Lin NJ; Li SL; Shen T
    Chin Med Sci J; 2007 Sep; 22(3):203-4. PubMed ID: 17966172
    [No Abstract]   [Full Text] [Related]  

  • 51. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
    Pulte D; Gondos A; Brenner H
    J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis.
    Ghayda RA; Lee J; Lee JY; Kim DK; Lee KH; Hong SH; Han YJ; Kim JS; Yang JW; Kronbichler A; Smith L; Koyanagi A; Jacob L; Shin JI
    Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32668763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The management of hematologic malignancies during the COVID-19 pandemic.
    Hus I; Salomon-Perzyński A; Tomasiewicz K; Robak T
    Expert Opin Pharmacother; 2021 Apr; 22(5):565-582. PubMed ID: 33342308
    [No Abstract]   [Full Text] [Related]  

  • 54. Wage-subsidised employment as a result of permanently reduced work capacity in a nationwide cohort of patients diagnosed with haematological malignancies.
    Horsboel TA; Nielsen CV; Nielsen B; Andersen NT; De Thurah A
    Acta Oncol; 2015 May; 54(5):743-9. PubMed ID: 25752974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of COVID-19 on Outcomes of Patients with Hematologic Malignancies: A Multicenter, Retrospective Study.
    Acar IH; Guner SI; Ak MA; Gocer M; Ozturk E; Atalay F; Sincan G; Yikilmaz AS; Ekinci O; Ince I; Gulturk E; Demir N; Dogan A; Ipek Y; Guvenc B
    Mediterr J Hematol Infect Dis; 2022; 14(1):e2022074. PubMed ID: 36425152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: Hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis.
    Sari I; Altuntas F; Hacioglu S; Kocyigit I; Sevinc A; Sacar S; Deniz K; Alp E; Eser B; Yildiz O; Kaynar L; Unal A; Cetin M
    Am J Hematol; 2008 Apr; 83(4):334-9. PubMed ID: 18069671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings.
    Rossi G; Salmanton-García J; Cattaneo C; Marchesi F; Dávila-Valls J; Martín-Pérez S; Itri F; López-García A; Glenthøj A; Gomes da Silva M; Besson C; Marchetti M; Weinbergerová B; Jaksic O; Jiménez M; Bilgin YM; Van Doesum J; Farina F; Žák P; Verga L; Collins GP; Bonuomo V; Van Praet J; Nucci M; Meers S; Espigado I; Fracchiolla NS; Valković T; Poulsen CB; Čolović N; Dragonetti G; Ledoux MP; Tascini C; Buquicchio C; Blennow O; Passamonti F; Machado M; Labrador J; Duarte RF; Schönlein M; Prezioso L; Falces-Romero I; Kulasekararaj A; Garcia-Vidal C; Fernández N; Abu-Zeinah G; Ormazabal-Vélez I; Adžić-Vukičević T; Piukovics K; Stoma I; Cuccaro A; Magliano G; Szotkowski T; González-López TJ; El-Ashwah S; Bergantim R; Sili U; Maertens J; Demirkan F; De Ramón C; Petzer V; Del Principe MI; Navrátil M; Dargenio M; Seval GC; Samarkos M; Ráčil Z; Pinczés LI; Lahmer T; Busca A; Méndez GA; Vena A; Biernat MM; Merelli M; Calbacho M; Barać A; Bavastro M; Limongelli A; Ilhan O; Wolf D; Çolak GM; García-Sanz R; Emarah Z; Mišković B; Gräfe SK; Mladenović M; Aiello TF; Núñez-Martín-Buitrago L; Nordlander A; Arellano E; Zambrotta GPM; Ammatuna E; Cabirta A; Sacchi MV; Nunes Rodrigues R; Hersby DS; Hanakova M; Rahimli L; Cordoba R; Cornely OA; Pagano L;
    Int J Infect Dis; 2023 Dec; 137():98-110. PubMed ID: 37863310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of neutropenia on the clinical outcomes of Staphylococcus aureus bacteremia in patients with hematologic malignancies: a 10-year experience in a tertiary care hospital.
    Ryu BH; Lee SC; Kim M; Eom Y; Jung J; Kim MJ; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
    Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):937-943. PubMed ID: 31925572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical characteristics of 199 discharged patients with COVID-19 in Fujian Province: A multicenter retrospective study between January 22nd and February 27th, 2020.
    Wang S; Chen Z; Lin Y; Lin L; Lin Q; Fang S; Shi Y; Zhuang X; Ye Y; Wang T; Zhang H; Shao C
    PLoS One; 2020; 15(11):e0242307. PubMed ID: 33180862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study.
    Mousavi SA; Rad S; Rostami T; Rostami M; Mousavi SA; Mirhoseini SA; Kiumarsi A
    Hematology; 2020 Dec; 25(1):383-388. PubMed ID: 33124971
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.